Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
To test the efficacy of acetazolamide for the treatment of uveitis-associated cystoid macular edema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Dec 1990
Typical duration for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1990
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 1994
CompletedFirst Submitted
Initial submission to the registry
September 23, 1999
CompletedFirst Posted
Study publicly available on registry
September 24, 1999
CompletedSeptember 17, 2009
September 1, 2009
September 23, 1999
September 16, 2009
Conditions
Interventions
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Whitcup SM, Csaky KG, Podgor MJ, Chew EY, Perry CH, Nussenblatt RB. A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. Ophthalmology. 1996 Jul;103(7):1054-62; discussion 1062-3. doi: 10.1016/s0161-6420(96)30567-8.
PMID: 8684794BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- NIH
Study Record Dates
First Submitted
September 23, 1999
First Posted
September 24, 1999
Study Start
December 1, 1990
Study Completion
June 1, 1994
Last Updated
September 17, 2009
Record last verified: 2009-09